Thrombosis atherosclerosis research institute free
The HRI Thrombosis group researches the prevention and treatment of heart disease and stroke, positioning Australia as a leader in the discovery therapies for the treatment of atherosclerosis and thrombosis. The Heart Research Institutes annual Awards for Excellence dinner, Illuminate, celebrated and recognised some of our most upand
Thrombosis and Atherosclerosis Research Institute. The Thrombosis and Atherosclerosis Research Institute (TaARI) works in partnership with Hamilton Health Sciences to conduct research in thrombosis, atherosclerosis and cardiovascular disease to improve prevention and bring laboratory discoveries to the patient bedside.
Peter L Gross of The Thrombosis& Atherosclerosis Research Institute, Hamilton (TaARI) Read 87 publications, 1 answers, and contact Peter L Gross on ResearchGate, the professional network for
Themes and Programs Using a benchtobedside approach, the TaARI research team is exploring the complex interplay among genetic, environmental and stochastic factors that impair vascular health and trigger thrombosis. Experimental thrombosis& atherosclerosis Genetic and molecular epidemiology of vascular disease Efficacy and safety of antithrombotic therapies Clinical thromboembolism Animal
Mar 20, 2014 Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Kearon C(1), Akl EA. Author information: (1)Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada; and. It takes about 3 months to complete active treatment of venous thromboembolism (VTE), with
Rating: 4.84 / Views: 302